Literature DB >> 11452695

[Identification of malignant breast lesions in Mexico].

L López-Carrillo1, L Torres-Sánchez, M López-Cervantes, C Rueda-Neria.   

Abstract

OBJECTIVE: To evaluate the modes of detection of breast malignancies in Mexico City and to estimate the number of patients diagnosed in advanced stages.
MATERIAL AND METHODS: This cross-sectional study was conducted between 1994 and 1996, among 256 women with a histological diagnosis of breast cancer, at three tertiary level public hospitals in Mexico City. Personal interviews were conducted to collect data on reproductive characteristics, clinical history, and breast cancer modes of detection. Data analysis consisted of percentages, odds ratios, and 95% confidence intervals.
RESULTS: Ninety percent of women sought medical care after identifying a breast lump by themselves. Only 10% of patients had a stage-I tumor; all 27 cases first identified by a physician were in stage II-B and higher.
CONCLUSIONS: An increasing trend of breast cancer mortality in Mexico City will persist, unless a greater proportion of tumors in situ is detected; this would require enhancing breast cancer screening programs and conducting an intense educational intervention among women at risk.

Entities:  

Mesh:

Year:  2001        PMID: 11452695

Source DB:  PubMed          Journal:  Salud Publica Mex        ISSN: 0036-3634


  8 in total

1.  [Psychological and social profile of women with mastectomies due to breast cancer].

Authors:  C Celis-Chacón; C A Gordillo-Galindo
Journal:  Aten Primaria       Date:  2006-02-28       Impact factor: 1.137

2.  Breast self-exam and patient interval associate with advanced breast cancer and treatment delay in Mexican women.

Authors:  E Leon-Rodriguez; C Molina-Calzada; M M Rivera-Franco; A Campos-Castro
Journal:  Clin Transl Oncol       Date:  2017-04-25       Impact factor: 3.405

3.  Prioritization of Patients with Abnormal Breast Findings in the Alerta Rosa Navigation Program to Reduce Diagnostic Delays.

Authors:  Jaime Tamez-Salazar; Teresa Mireles-Aguilar; Cynthia de la Garza-Ramos; Marisol Garcia-Garcia; Ana S Ferrigno; Alejandra Platas; Cynthia Villarreal-Garza
Journal:  Oncologist       Date:  2020-08-25

4.  Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.

Authors:  Cynthia Villarreal-Garza; Rosa María Alvarez-Gómez; Carlos Pérez-Plasencia; Luis A Herrera; Josef Herzog; Danielle Castillo; Alejandro Mohar; Clementina Castro; Lenny N Gallardo; Dolores Gallardo; Miguel Santibáñez; Kathleen R Blazer; Jeffrey N Weitzel
Journal:  Cancer       Date:  2014-09-18       Impact factor: 6.860

5.  Evaluation of breast cancer knowledge among health promoters in Mexico before and after focused training.

Authors:  Nancy L Keating; Elena M Kouri; Héctor Arreola Ornelas; Oscar Méndez; Laura Magaña Valladares; Felicia Marie Knaul
Journal:  Oncologist       Date:  2014-09-17

6.  The impact of family history of breast cancer on knowledge, attitudes, and early detection practices of Mexican women along the Mexico-US border.

Authors:  Yelena Bird; Matthew P Banegas; John Moraros; Sasha King; Surasri Prapasiri; Beti Thompson
Journal:  J Immigr Minor Health       Date:  2011-10

7.  Access to care issues adversely affect breast cancer patients in Mexico: oncologists' perspective.

Authors:  Yanin Chavarri-Guerra; Jessica St Louis; Pedro E R Liedke; Heather Symecko; Cynthia Villarreal-Garza; Alejandro Mohar; Dianne M Finkelstein; Paul E Goss
Journal:  BMC Cancer       Date:  2014-09-09       Impact factor: 4.430

8.  An educational strategy for improving knowledge about breast and cervical cancer prevention among Mexican middle school students.

Authors:  Ana Laura Calderón-Garcidueñas; Yolanda Flores-Peña; Silvia De León-Leal; Carlos Alberto Vázquez-Martínez; Ana Gabriela Farías-Calderón; Guadalupe Melo-Santiesteban; Rosa María Elizondo-Zapién; Dulce María Hernandez-Hernandez; Rubén Garza-Moya; Ricardo Martín Cerda-Flores
Journal:  Prev Med Rep       Date:  2015-04-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.